• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Bioceres Crop Solutions Corp. (Amendment)

    2/14/24 4:44:20 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials
    Get the next $BIOX alert in real time by email
    SC 13G/A 1 ef20021543_sc13ga.htm SC 13G/A
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C.  20549


     
    SCHEDULE 13G
     
    Under the Securities Exchange Act of 1934
    (Amendment No. 1) *
     
    BIOCERES CROP SOLUTIONS CORP.
     
    ORDINARY SHARES, PAR VALUE $0.0001 PER SHARE
     (Title of Class of Securities)
     
    G1117K114
     (CUSIP Number)
     
     December 31, 2023
     (Date of Event which Requires Filing of this Statement)
     
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
      ☒
    Rule 13d-1(b)
     
      ☐
    Rule 13d-1(c)
     
      ☐
    Rule 13d-1(d)
     
    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
     
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
     
    Continued on following pages
    Page 1 of 5 Pages



    CUSIP No. G1117K114
    Page 2 of 5 Pages
    1
    NAMES OF REPORTING PERSONS
     
     
    SOLEL PARTNERS, LP
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     

     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    4,579,364
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    0
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    4,579,364
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    0
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    4,579,364
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    7.3%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    IA
     
     
     
     


    Page 3 of 5 Pages
    Item 1(a).
    Name of Issuer:

    Bioceres Crop Solutions Corp.

    Item 1(b).
    Address of Issuer’s Principal Executive Offices:

    Ocampo 210 bis, Predio CCT, Rosario
    Province of Santa Fe, Argentina

    Item 2(a).
    Name of Person Filing

    Solel Partners LP (the “Reporting Person”)

    Item 2(b).
    Address of Principal Business Office or, if None, Residence:

    Solel Partners LP
    699 Boylston Street, 15th Floor
    Boston, MA 02116

    Item 2(c).
    Citizenship:

    United States - Delaware

    Item 2(d).
    Title of Class of Securities:
     
    Ordinary shares, par value $0.0001 per share (the “Shares”)

    Item 2(e).
    CUSIP Number:

    G1117K114

    Item 3.
    If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

    (e)
    ☒
    An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

    Item 4.
    Ownership:

    Item 4(a).
    Amount Beneficially Owned:  4,579,364

    Item 4(b).
    Percent of Class: 7.3%

    Item 4(c).
    Number of Shares as to which such person has:
     
    (i) Sole power to vote or direct the vote: 4,579,364
     
    (ii) Shared power to vote or direct the vote: 0
     
    (iii) Sole power to dispose or direct the disposition of: 4,579,364
     
    (iv) Shared power to dispose or direct the disposition of: 0


    Page 4 of 5 Pages
    Item 5.
    Ownership of Five Percent or Less of a Class:

    This Item 5 is not applicable.

    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person:

    Solel-Bioceres SPV, L.P. is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares covered by this Statement that may be deemed to be beneficially owned by the Reporting Person.

    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:

    This Item 7 is not applicable.

    Item 8.
    Identification and Classification of Members of the Group:

    This Item 8 is not applicable.

    Item 9.
    Notice of Dissolution of Group:

    This Item 9 is not applicable.

    Item 10.
    Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
     

    Page 5 of 5 Pages
    SIGNATURE
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    February 14, 2024
     
     
    Solel Partners LP
       
     
    By: 
    /s/ William Stone
     
    Name: William Stone
     
    Title: Chief Compliance Officer



    Get the next $BIOX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BIOX

    DatePrice TargetRatingAnalyst
    7/19/2024$17.00Buy
    Canaccord Genuity
    7/2/2024$15.00Buy
    ROTH MKM
    4/6/2023$15.00Outperform
    Oppenheimer
    9/30/2022$22.50Buy
    Canaccord Genuity
    10/8/2021$21.00Buy
    ROTH Capital
    More analyst ratings

    $BIOX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Bioceres Crop Solutions Reports Fiscal Third Quarter 2025 Financial and Operational Results

      Total revenues in 3Q25 were $60.6 million 3Q25 net loss was $1.6 million and Adjusted EBITDA1 was $9.0 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal third quarter ended March 31, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. Financial & Business Highlights Total revenues were $60

      5/21/25 7:01:00 AM ET
      $BIOX
      Agricultural Chemicals
      Industrials
    • Bioceres Crop Solutions to Host Fiscal Third Quarter 2025 Financial Results Conference Call on Wednesday, May 21, 2025 at 8:30 a.m. Eastern Time

      Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Wednesday, May 21, 2025 at 8:30 a.m. Eastern Time to discuss its results for the fiscal third quarter ended March 31, 2025. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco, Chief Financial Officer Enrique Lopez Lecube, Chief Commercial Officer Milen Marinov and Head of Investor Relations Paula Savanti will host the conference ca

      5/9/25 4:30:00 PM ET
      $BIOX
      Agricultural Chemicals
      Industrials
    • Bioceres Crop Solutions Announces EPA Registration of Rinotec Insecticide and Nematicide Platform, a Game-Changing Solution for Integrated Pest Management

      Bioceres Crop Solutions (NASDAQ:BIOX), a leading global provider of sustainable crop productivity solutions, and ProFarm Group, a subsidiary of BIOX, today announced that their innovative insecticide and nematicide platform, Rinotec, has received a federal registration from the U.S. Environmental Protection Agency (EPA). Rinotec is exempt from residue tolerance requirements, reflecting the EPA's assessment of its negligible risk to human health and non-target organisms. Rinotec has already been approved for commercialization in Brazil. With both U.S. and Brazilian registrations now in place, Bioceres Crop Solutions is poised to advance its regulatory and commercial strategies in these regi

      3/11/25 7:30:00 AM ET
      $BIOX
      Agricultural Chemicals
      Industrials

    $BIOX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Canaccord Genuity resumed coverage on Bioceres with a new price target

      Canaccord Genuity resumed coverage of Bioceres with a rating of Buy and set a new price target of $17.00

      7/19/24 8:32:10 AM ET
      $BIOX
      Agricultural Chemicals
      Industrials
    • ROTH MKM resumed coverage on Bioceres with a new price target

      ROTH MKM resumed coverage of Bioceres with a rating of Buy and set a new price target of $15.00

      7/2/24 8:01:46 AM ET
      $BIOX
      Agricultural Chemicals
      Industrials
    • Oppenheimer initiated coverage on Bioceres with a new price target

      Oppenheimer initiated coverage of Bioceres with a rating of Outperform and set a new price target of $15.00

      4/6/23 7:19:53 AM ET
      $BIOX
      Agricultural Chemicals
      Industrials

    $BIOX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Bioceres Crop Solutions Corp.

      SC 13G - Bioceres Crop Solutions Corp. (0001769484) (Subject)

      10/23/24 2:32:38 PM ET
      $BIOX
      Agricultural Chemicals
      Industrials
    • Amendment: SEC Form SC 13D/A filed by Bioceres Crop Solutions Corp.

      SC 13D/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)

      9/20/24 9:09:41 PM ET
      $BIOX
      Agricultural Chemicals
      Industrials
    • SEC Form SC 13D/A filed by Bioceres Crop Solutions Corp. (Amendment)

      SC 13D/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)

      3/25/24 8:58:35 AM ET
      $BIOX
      Agricultural Chemicals
      Industrials

    $BIOX
    SEC Filings

    See more
    • SEC Form 6-K filed by Bioceres Crop Solutions Corp.

      6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)

      5/21/25 4:44:06 PM ET
      $BIOX
      Agricultural Chemicals
      Industrials
    • SEC Form 6-K filed by Bioceres Crop Solutions Corp.

      6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)

      3/11/25 4:01:14 PM ET
      $BIOX
      Agricultural Chemicals
      Industrials
    • SEC Form 6-K filed by Bioceres Crop Solutions Corp.

      6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)

      2/12/25 8:04:36 AM ET
      $BIOX
      Agricultural Chemicals
      Industrials

    $BIOX
    Financials

    Live finance-specific insights

    See more
    • Bioceres Crop Solutions Reports Fiscal Third Quarter 2025 Financial and Operational Results

      Total revenues in 3Q25 were $60.6 million 3Q25 net loss was $1.6 million and Adjusted EBITDA1 was $9.0 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal third quarter ended March 31, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. Financial & Business Highlights Total revenues were $60

      5/21/25 7:01:00 AM ET
      $BIOX
      Agricultural Chemicals
      Industrials
    • Bioceres Crop Solutions to Host Fiscal Third Quarter 2025 Financial Results Conference Call on Wednesday, May 21, 2025 at 8:30 a.m. Eastern Time

      Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Wednesday, May 21, 2025 at 8:30 a.m. Eastern Time to discuss its results for the fiscal third quarter ended March 31, 2025. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco, Chief Financial Officer Enrique Lopez Lecube, Chief Commercial Officer Milen Marinov and Head of Investor Relations Paula Savanti will host the conference ca

      5/9/25 4:30:00 PM ET
      $BIOX
      Agricultural Chemicals
      Industrials
    • Bioceres Crop Solutions Reports Fiscal Second Quarter 2025 Financial and Operational Results

      Total revenues in 2Q25 were $106.7 million 2Q25 net income was $0.6 million and Adjusted EBITDA1 was $15.4 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal second quarter ended December 31, 2024. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. Financial & Business Highlights Revenues in

      2/11/25 6:18:00 PM ET
      $BIOX
      Agricultural Chemicals
      Industrials